The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Identification of human brain tumour initiating cells
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., Henkelman, R. M., Cusimano, M. D., & Dirks, P. B. (2004) · Nature · doi:10.1038/nature03128 · Cited by 7,433
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
Nowell, P. C. (1976) · Science · doi:10.1126/science.959840 · Cited by 6,471
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Bonnet, D., & Dick, J. E. (1997) · Nature Medicine · doi:10.1038/nm0797-730 · Cited by 5,864
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., Jacquemier, J., Viens, P., Kleer, C. G., Liu, S., et al. (2007) · Cell Stem Cell · doi:10.1016/j.stem.2007.08.014 · Cited by 4,012
Cited by
Items 101–189 of 189
Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities
Toole, B. P. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0479 · Cited by 362
Adult stem cells in the endometrium
Gargett, C. E., & Masuda, H. (2010) · Molecular Human Reproduction · doi:10.1093/molehr/gaq061 · Cited by 361
pH-Sensitive ZnO Quantum Dots–Doxorubicin Nanoparticles for Lung Cancer Targeted Drug Delivery
Cai, X., Luo, Y., Zhang, W., Du, D., & Lin, Y. (2016) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b04933 · Cited by 359
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets
Klingenberg, M., Matsuda, A., Diederichs, S., & Patel, T. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.009 · Cited by 354
Role of integrated cancer nanomedicine in overcoming drug resistance
Iyer, A. K., Singh, A., Ganta, S., & Amiji, M. M. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.012 · Cited by 343
Drug resistance in metastatic castration-resistant prostate cancer
Seruga, B., Ocana, A., & Tannock, I. F. (2011) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.136 · Cited by 336
Functional Evidence that the Self-Renewal Gene NANOG Regulates Human Tumor Development
Jeter, C. R., Badeaux, M., Choy, G., Chandra, D., Patrawala, L., Liu, C., Calhoun-Davis, T., Zaehres, H., Daley, G. Q., & Tang, D. G. (2009) · Stem Cells · doi:10.1002/stem.29 · Cited by 335
Forkhead Homeobox Type O Transcription Factors in the Responses to Oxidative Stress
Storz, P. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3405 · Cited by 333
The role of EZH2 in tumour progression
Chang, C.-J., & Hung, M.-C. (2012) · British Journal of Cancer · doi:10.1038/bjc.2011.551 · Cited by 332
Cancer stem cell surface markers on normal stem cells
Kim, W.-T., & Ryu, C. J. (2017) · BMB Reports · doi:10.5483/bmbrep.2017.50.6.039 · Cited by 332
Factors involved in cancer metastasis: a better understanding to “seed and soil” hypothesis
Liu, Q., Zhang, H., Jiang, X., Qian, C., Liu, Z., & Luo, D. (2017) · Molecular Cancer · doi:10.1186/s12943-017-0742-4 · Cited by 332
Focal adhesion signaling and therapy resistance in cancer
Eke, I., & Cordes, N. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.07.009 · Cited by 330
Human germ cell tumours from a developmental perspective
Oosterhuis, J. W., & Looijenga, L. H. J. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0178-9 · Cited by 328
Reactive Oxygen Species in Cancer Stem Cells
Shi, X., Zhang, Y., Zheng, J., & Pan, J. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4529 · Cited by 325
ABCG2: A potential marker of stem cells and novel target in stem cell and cancer therapy
Ding, X.-W., Wu, J.-H., & Jiang, C.-P. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.02.012 · Cited by 323
EpCAM in carcinogenesis: the good, the bad or the ugly
van der Gun, B. T. F., Melchers, L. J., Ruiters, M. H. J., de Leij, L. F. M. H., McLaughlin, P. M. J., & Rots, M. G. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq187 · Cited by 322
Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment
Sun, X.-X., & Yu, Q. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.92 · Cited by 318
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review
Chiurillo, M. A. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.84 · Cited by 317
Lugli, A., Iezzi, G., Hostettler, I., Muraro, M. G., Mele, V, Tornillo, L., Carafa, V, Spagnoli, G., Terracciano, L., & Zlobec, I. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605762 · Cited by 313
lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions
McCabe, E. M., & Rasmussen, T. P. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.12.012 · Cited by 312
Bisson, I., & Prowse, D. M. (2009) · Cell Research · doi:10.1038/cr.2009.43 · Cited by 308
GATA3 in development and cancer differentiation: Cells GATA have it!
Chou, J., Provot, S., & Werb, Z. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.21943 · Cited by 304
Glycolysis gatekeeper PDK1 reprograms breast cancer stem cells under hypoxia
Peng, F., Wang, J.-H., Fan, W.-J., Meng, Y.-T., Li, M.-M., Li, T.-T., Cui, B., Wang, H.-F., Zhao, Y., An, F., et al. (2018) · Oncogene · doi:10.1038/onc.2017.368 · Cited by 303
Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis
Battula, V. L., Shi, Y., Evans, K. W., Wang, R.-Y., Spaeth, E. L., Jacamo, R. O., Guerra, R., Sahin, A. A., Marini, F. C., Hortobagyi, G., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59735 · Cited by 302
Grosse‐Gehling, P., Fargeas, C. A., Dittfeld, C., Garbe, Y., Alison, M. R., Corbeil, D., & Kunz‐Schughart, L. A. (2013) · The Journal of Pathology · doi:10.1002/path.4086 · Cited by 301
Distinct types of tumor-initiating cells form human colon cancer tumors and metastases
Dieter, S. M., Ball, C. R., Hoffmann, C. M., Nowrouzi, A., Herbst, F., Zavidij, O., Abel, U., Arens, A., Weichert, W., Brand, K., et al. (2011) · Cell stem cell · doi:10.1016/j.stem.2011.08.010 · Cited by 297
Kim, S.-Y., Kang, J. W., Song, X., Kim, B. K., Yoo, Y. D., Kwon, Y. T., & Lee, Y. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.007 · Cited by 297
Shan, J., Shen, J., Liu, L., Xia, F., Xu, C., Duan, G., Xu, Y., Ma, Q., Yang, Z., Zhang, Q., et al. (2012) · Hepatology · doi:10.1002/hep.25745 · Cited by 296
“The theory of CSCs proposes a hierarchical organization of cells within the tumor, in which a subpopulation of stem-like cells is responsible for sustaining tumor growth.(2,3) The concept of CSCs has significant clinical implications: CSCs have been shown to be more resistant to chemotherapy and radiotherapy,(4) and C…”
BackgroundRisk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Kempers, M. J., Kuiper, R. P., Ockeloen, C. W., Chappuis, P. O., Hutter, P., Rahner, N., Schackert, H. K., Steinke, V., Holinski-Feder, E., Morak, M., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70265-5 · Cited by 295
Blick, T., Hugo, H., Widodo, E., Waltham, M., Pinto, C., Mani, S. A., Weinberg, R. A., Neve, R. M., Lenburg, M. E., & Thompson, E. W. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9175-z · Cited by 292
Therapy resistance mediated by cancer stem cells
Steinbichler, T. B., Dudás, J., Skvortsov, S., Ganswindt, U., Riechelmann, H., & Skvortsova, I.-I. (2018) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2018.11.006 · Cited by 286
miR-7 Suppresses Brain Metastasis of Breast Cancer Stem-Like Cells By Modulating KLF4
Okuda, H., Xing, F., Pandey, P. R., Sharma, S., Watabe, M., Pai, S. K., Mo, Y.-Y., Iiizumi-Gairani, M., Hirota, S., Liu, Y., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-2037 · Cited by 285
Rao, W., Wang, H., Han, J., Zhao, S., Dumbleton, J., Agarwal, P., Zhang, W., Zhao, G., Yu, J., Zynger, D. L., et al. (2015) · ACS Nano · doi:10.1021/nn506928p · Cited by 281
Redox regulation in stem-like cancer cells by CD44 variant isoforms
Nagano, O., Okazaki, S., & Saya, H. (2013) · Oncogene · doi:10.1038/onc.2012.638 · Cited by 280
Sinonasal carcinoma: clinical, pathological, genetic and therapeutic advances
Llorente, J. L., López, F., Suárez, C., & Hermsen, M. A. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.97 · Cited by 280
Liu, Z., Li, Q., Li, K., Chen, L., Li, W., Hou, M., Liu, T., Yang, J., Lindvall, C., Björkholm, M., et al. (2013) · Oncogene · doi:10.1038/onc.2012.441 · Cited by 276
Tamada, M., Nagano, O., Tateyama, S., Ohmura, M., Yae, T., Ishimoto, T., Sugihara, E., Onishi, N., Yamamoto, T., Yanagawa, H., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3024 · Cited by 275
The evolving concept of liver cancer stem cells
Nio, K., Yamashita, T., & Kaneko, S. (2017) · Molecular Cancer · doi:10.1186/s12943-016-0572-9 · Cited by 274
Nano-Based Approved Pharmaceuticals for Cancer Treatment: Present and Future Challenges
Rodríguez, F., Caruana, P., De la Fuente, N., Español, P., Gámez, M., Balart, J., Llurba, E., Rovira, R., Ruiz, R., Martín-Lorente, C., et al. (2022) · Biomolecules · doi:10.3390/biom12060784 · Cited by 274
Selection and adaptation during metastatic cancer progression
Klein, C. A. (2013) · Nature · doi:10.1038/nature12628 · Cited by 273
Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic Leukemia
Ebinger, S., Özdemir, E. Z., Ziegenhain, C., Tiedt, S., Castro Alves, C., Grunert, M., Dworzak, M., Lutz, C., Turati, V. A., Enver, T., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.11.002 · Cited by 271
An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ
Behbod, F., Kittrell, F. S., LaMarca, H., Edwards, D., Kerbawy, S., Heestand, J. C., Young, E., Mukhopadhyay, P., Yeh, H.-W., Allred, D. C., et al. (2009) · Breast Cancer Research · doi:10.1186/bcr2358 · Cited by 268
YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma
Bai, Y., Yang, C., Wu, R., Huang, L., Song, S., Li, W., Yan, P., Lin, C., Li, D., & Zhang, Y. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00332 · Cited by 267
Tinganelli, W., & Durante, M. (2020) · Cancers · doi:10.3390/cancers12103022 · Cited by 267
Shien, K., Toyooka, S., Yamamoto, H., Soh, J., Jida, M., Thu, K. L., Hashida, S., Maki, Y., Ichihara, E., Asano, H., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4136 · Cited by 267
Embryonic stem cell markers expression in cancers
Schoenhals, M., Kassambara, A., Vos, J. D., Hose, D., Moreaux, J., & Klein, B. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.02.156 · Cited by 265
Wang, Y., Yu, Y., Tsuyada, A., Ren, X., Wu, X., Stubblefield, K., Rankin-Gee, E. K., & Wang, S. E. (2011) · Oncogene · doi:10.1038/onc.2010.531 · Cited by 263
Huang, R., Wang, S., Wang, N., Zheng, Y., Zhou, J., Yang, B., Wang, X., Zhang, J., Guo, L., Wang, S., et al. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-2435-y · Cited by 263
A Review on Electroporation-Based Intracellular Delivery
Shi, J., Ma, Y., Zhu, J., Chen, Y., Sun, Y., Yao, Y., Yang, Z., & Xie, J. (2018) · Molecules · doi:10.3390/molecules23113044 · Cited by 261
Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling
Rajasekhar, V. K., Studer, L., Gerald, W., Socci, N. D., & Scher, H. I. (2011) · Nature Communications · doi:10.1038/ncomms1159 · Cited by 259
Hyaluronic Acid: A Powerful Biomolecule with Wide-Ranging Applications—A Comprehensive Review
Iaconisi, G. N., Lunetti, P., Gallo, N., Cappello, A. R., Fiermonte, G., Dolce, V., & Capobianco, L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210296 · Cited by 258
Kuo, T.-C., Chen, C.-T., Baron, D., Onder, T. T., Loewer, S., Almeida, S., Weismann, C. M., Xu, P., Houghton, J.-M., Gao, F.-B., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2332 · Cited by 258
Qhattal, H. S. S., & Liu, X. (2011) · Molecular Pharmaceutics · doi:10.1021/mp2000428 · Cited by 254
Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer
Deep, G., & Agarwal, R. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9237-0 · Cited by 253
Ma, J., Zhang, Y., Tang, K., Zhang, H., Yin, X., Li, Y., Xu, P., Sun, Y., Ma, R., Ji, T., et al. (2016) · Cell Research · doi:10.1038/cr.2016.53 · Cited by 253
Mammosphere Formation in Breast Carcinoma Cell Lines Depends upon Expression of E-cadherin
Manuel Iglesias, J., Beloqui, I., Garcia-Garcia, F., Leis, O., Vazquez-Martin, A., Eguiara, A., Cufi, S., Pavon, A., Menendez, J. A., Dopazo, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077281 · Cited by 212
Wu, Z., Wei, D., Gao, W., Xu, Y., Hu, Z., Ma, Z., Gao, C., Zhu, X., & Li, Q. (2015) · Cell Stem Cell · doi:10.1016/j.stem.2015.05.016 · Cited by 149
The Tumor Microenvironment: A Pitch for Multiple Players
Schiavoni, G., Gabriele, L., & Mattei, F. (2013) · Frontiers in Oncology · doi:10.3389/fonc.2013.00090 · Cited by 147
Bioengineered 3D models of human pancreatic cancer recapitulate in vivo tumour biology
Osuna de la Peña, D., Trabulo, S. M. D., Collin, E., Liu, Y., Sharma, S., Tatari, M., Behrens, D., Erkan, M., Lawlor, R. T., Scarpa, A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25921-9 · Cited by 138
The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma
Zeng, S. S., Yamashita, T., Kondo, M., Nio, K., Hayashi, T., Hara, Y., Nomura, Y., Yoshida, M., Hayashi, T., Oishi, N., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.08.024 · Cited by 140
The hypoxic tumor microenvironment in vivo selects the cancer stem cell fate of breast cancer cells
Kim, H., Lin, Q., Glazer, P. M., & Yun, Z. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-0944-8 · Cited by 122
Rainusso, N., Brawley, V. S., Ghazi, A., Hicks, M. J., Gottschalk, S., Rosen, J. M., & Ahmed, N. (2012) · Cancer Gene Therapy · doi:10.1038/cgt.2011.83 · Cited by 114
Lung cancer stem cell markers as therapeutic targets: An update on signaling pathways and therapies
Zheng, Y., Wang, L., Yin, L., Yao, Z., Tong, R., Xue, J., & Lu, Y. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.873994 · Cited by 97
Meng, Z., Li, T., Ma, X., Wang, X., Van Ness, C., Gan, Y., Zhou, H., Tang, J., Lou, G., Wang, Y., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0314 · Cited by 97
Chwalek, K., Bray, L. J., & Werner, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.006 · Cited by 91
Aran, V., Devalle, S., Meohas, W., Heringer, M., Cunha Caruso, A., Pinheiro Aguiar, D., Leite Duarte, M. E., & Moura Neto, V. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103340 · Cited by 87
Zhang, B.-L., Li, D., Gong, Y.-L., Huang, Y., Qin, D.-Y., Jiang, L., Liang, X., Yang, X., Gou, H.-F., Wang, Y.-S., et al. (2019) · Human Gene Therapy · doi:10.1089/hum.2018.229 · Cited by 88
A matter of life and death: stem cell survival in tissue regeneration and tumour formation
Soteriou, D., & Fuchs, Y. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.122 · Cited by 87
Palmer, N. P., Schmid, P. R., Berger, B., & Kohane, I. S. (2012) · Genome Biology · doi:10.1186/gb-2012-13-8-r71 · Cited by 86
Herrmann, I., Baeuerle, P. A., Friedrich, M., Murr, A., Filusch, S., Rüttinger, D., Majdoub, M. W., Sharma, S., Kufer, P., Raum, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013474 · Cited by 85
Podergajs, N., Motaln, H., Rajčević, U., Verbovšek, U., Koršič, M., Obad, N., Espedal, H., Vittori, M., Herold-Mende, C., Miletic, H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.5477 · Cited by 81
Metformin and Cancer Stem Cells: Old Drug, New Targets
Bednar, F., & Simeone, D. M. (2012) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0026 · Cited by 51
“Subsequent work carried out bymultiple groups experimentally verified the CSC hypothesis, first in breast tumors and subsequently in other solid malignancies (2).”
BackgroundZhang, H., Steed, A., Co, M., & Chen, X. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.32 · Cited by 50
“CSCs have the nature to be slow-cycling or quiescent, spending the majority of time in G0 and thus can circumvent the chemotherapy or radiotherapy targeting the rapidly dividing tumor cells[20].”
BackgroundXie, H., Li, C., Dang, Q., Chang, L. S., & Li, L. (2016) · Oncotarget · doi:10.18632/oncotarget.6372 · Cited by 49
“com/oncotarget [32, 33], as well as their secreted cytokines and growth factors (for example, IL-6 and stromal cell-derived factor 1), and altering the ECM [34] may also play key roles to development of docetaxel resistance.”
BackgroundChi, H.-C., Tsai, C.-Y., Wang, C.-S., Yang, H.-Y., Lo, C.-H., Wang, W.-J., Lee, K.-F., Lai, L.-Y., Hong, J.-H., Chang, Y.-F., et al. (2020) · Oncogene · doi:10.1038/s41388-020-01390-0 · Cited by 46
Mammalian cells acquire epigenetic hallmarks of human cancer during immortalization
Tommasi, S., Zheng, A., Weninger, A., Bates, S. E., Li, X. A., Wu, X., Hollstein, M., & Besaratinia, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1051 · Cited by 45
Gordon, K., Clouaire, T., Bao, X. X., Kemp, S. E., Xenophontos, M., de Las Heras, J. I., & Stancheva, I. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1351 · Cited by 44
CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer
Sato-Dahlman, M., Miura, Y., Huang, J. L., Hajeri, P., Jacobsen, K., Davydova, J., & Yamamoto, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18340 · Cited by 43
“Recent data suggest that CSC population is phenotypically heterogeneous among tumor types and even within the same tumor subtype [45, 46].”
BackgroundRegulation of Stem Cell Plasticity: Mechanisms and Relevance to Tissue Biology and Cancer
Strauss, R., Hamerlik, P., Lieber, A., & Bartek, J. (2012) · Molecular Therapy · doi:10.1038/mt.2012.2 · Cited by 41
Arab-Bafrani, Z., Zabihi, E., Jafari, S. M., Khoshbin-Khoshnazar, A., Mousavi, E., Khalili, M., & Babaei, A. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120828 · Cited by 39
Mesothelial Cells Facilitate Cancer Stem like properties in spheroids of ovarian cancer cells
Shishido, A., Mori, S., Yokoyama, Y., Hamada, Y., Minami, K., Qian, Y., Wang, J., Hirose, H., Wu, X., Kawaguchi, N., et al. (2018) · Oncology Reports · doi:10.3892/or.2018.6605 · Cited by 34
“CSCs have been identified in many types of solid tumors and are relatively quiescent, can self-renew, grow as spheroids and make up the tumor bulk by generating differentiated daughter cells through asymmetric division (16,17).”
BackgroundPolymer Thin Film-Induced Tumor Spheroids Acquire Cancer Stem Cell-like Properties
Choi, M., Yu, S. J., Choi, Y., Lee, H. R., Lee, E., Lee, E., Lee, Y., Song, J., Son, J. G., Lee, T. G., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-0927 · Cited by 32
Min, S., Wang, X., Du, Q., Gong, H., Yang, Y., Wang, T., Wu, N., Liu, X., Li, W., Zhao, C., et al. (2020) · Cancer Biology & Therapy · doi:10.1080/15384047.2020.1763147 · Cited by 28
“Cancer stem cells (CSCs) have been suggested as one reason that tumors recur, as they maintain the ability to selfrenew and differentiate.(6) CSCs have been discovered in numerous cancers, including NSCLC.”
BackgroundValcz, G., Buzás, E. I., Szállási, Z., Kalmár, A., Krenács, T., Tulassay, Z., Igaz, P., & Molnár, B. (2018) · npj Breast Cancer · doi:10.1038/s41523-018-0071-9 · Cited by 27
Cell hierarchy, metabolic flexibility and systems approaches to cancer treatment
M. Herst, P., & V. Berridge, M. (2013) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201011314030005 · Cited by 16
Epigenetic modification in gliomas: role of the histone methyltransferase EZH2
Bian, E.-B., Li, J., He, X.-J., Zong, G., Jiang, T., Li, J., & Zhao, B. (2014) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2014.941807 · Cited by 12
Rapamycin inhibited the function of lung CSCs via SOX2
Xie, L.-X., Sun, F.-F., He, B.-F., Zhan, X.-F., Song, J., Chen, S.-S., Yu, S.-C., & Ye, X.-Q. (2016) · Tumor Biology · doi:10.1007/s13277-015-4341-y · Cited by 12
Beck, D., Cao, H., Tian, F., Huang, Y., Jiang, M., Zhao, H., Tai, X., Xu, W., Kosasih, H. J., Kealy, D. J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-54096-2 · Cited by 9
TBX3 stimulates proliferation and stem cell self-renewal in bladder carcinoma.
(2023) · PubMed · doi:10.14670/hh-18-496 · Cited by 4
Metadata
- Authors
- Visvader, J. E., & Lindeman, G. J.
- Venue
- Nature Reviews Cancer
- Published
- 2008-09-11
- Volume
- 8
- Issue
- 10
- Pages
- 755-768
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1999356404
- Cited by
- 3,429
- References
- 118
- FWCI
- 11.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.